Douglas A. Hubatsch
United States Army Research Office(US)
Publications by Year
Research Areas
Glaucoma and retinal disorders, Ocular Surface and Contact Lens, Corneal surgery and disorders, Ophthalmology and Eye Disorders, Retinal Diseases and Treatments
Most-Cited Works
- → The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor(1999)255 cited
- → Mechanical stimulation increases expression of acetylcholinesterase in cultured myotubes(1997)33 cited
- → Effect of benzalkonium chloride–free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study(2015)26 cited
- → Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost(2016)17 cited
- → Effects of K+ channel blockers on the anoxic response of CNS myelinated axons(1998)17 cited
- → 24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%(2018)16 cited
- → A Randomized Trial of Fixed-Dose Combination Brinzolamide 1%/Brimonidine 0.2% as Adjunctive Therapy to Travoprost 0.004%(2016)15 cited
- → Late-day intraocular pressure–lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial(2014)12 cited
- → <p>Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension</p>(2019)12 cited
- → Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy(2015)12 cited